Clozapine: Neuropsychological and neuroimaging studies;Clozapina: Estudios neuropsicolögicos y de resonancia magnética

Actas Espanolas de Psiquiatria

Volumn 27, Issue 5, 1999, Pages 341-346

  Perez Gomez M ^a   Junque C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Clozapine; Frontal; Neuroimaging; Neuropsychology; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

BRAIN; COGNITION; DRUG EFFECT; FRONTAL LOBE; HUMAN; MEMORY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; REVIEW; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; COGNITION; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 0033183390     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Junqué C. Neuropsicología y trastornos psiquiátricos. En: Vallejo J, ed. UPDATE Psiquiatría. Barcelona: Masson; 1995. p. 79-90.
2. Cassens G, Inglis A, Appelbaum PS, Gutheil TG. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bull 1990;16(3):477-98.
3. King DI. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990;157: 799-811.
4. Bilder RM, Turkel E, Lipschutz-Broch L, Lieberman JA. Antipsychotic medication effects on neuropsychological functions. Psychopharmacol Bull 1992; 28:353-66.
5. Breier A, Buchanan RW, Kirkpatrick B, David OR, Irish D, Summerfelt A, Carpenter WT. Effect of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994; 151:20-6.
6. Lieberman JA, Safferman AZ. Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 1992;63:51-70.
7. Casey DE. Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology (Berl) 1989;99(Supl):47-53.
8. Sayers AC, Amsler HA. Clozapine. Pharmacol Biochem Properties Drug Substances 1977;1:1-31.
9. Seeger TF, Thai L, Gardner EL. Behavioral and biochemical aspects on neuroleptic-induced dopaminergic supersensivity: Studies with chronic clozapine and haloperidol. Psychopharmacology 1982;76: 182-7.
10. Breier A, Buchanan RW, Irish D, Carpenter WT. Clozapine in schizophrenic outpatients: outcome and longterm response patterns. Hosp Community Psychiatry 1993;44:1145-9.
11. Goldberg TE, Weinberger DR. The effects of clozapine on neurocognition: an overview. J Clin Psychiatry 1994;55(Supl B):88-90.
12. Classen W, Laux G. Sensorimotor and cognitive performance of schizophreniac inpatients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry 1988,21:295-7.
13. Goldberg TE, Greengerg RD, Griffin SJ, Gold J, Kleinman JE, Pickar D, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-8.
14. Carter J, Thrasher S, Thornicroft G. Cognitive impairment and clozapine. Br J Psychiatry 1994;161:132-3.
15. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993; 34:702-12.
16. Buchanan RW, Hostein C, Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 1994;36:717-25.
17. Lee MA, Thompson PA, Meltzer HY. Effect of clozapina on cognitive function in schizophrenia. J Clin Psychiatry 1994;55(Supl B):82-7.
18. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-80.
19. Grawe RW, Levander S. Smooth pursuit eye movement and neuropsychological impairments in schizophrenia. Acta Psychiatr Scand 1995;92:108-14.
20. Holzman PS, Levy DL, Proctor LR. Smooth pursuit eye movement, attention, and schizophrenia. Arch Gen Psychiatry 1976;33:1415-20.
21. Rezai K, Andreasen NC, Alliger R, Cohen G, Swayze V, O'Leary DS. The neuropsychology of the prefrontal cortex. Arch Neurol 1993;50:636-42.
22. Heilman KM, Voeller KKS, Nadeau SE. A possible pathophysiologic substrate of attention-deficit hyperactivity disorder. J Child Neurol 1991;6(Supl):74-9.
23. Junqué C, Jurado MA. Envejecimiento y demencias. Barcelona: Martínez Roca; 1994.
24. Heckers S, Heinsen H, Heinsen Y, Beckmann H. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 1991;29:556-66.
25. Hokama H, Shenton ME, Nestor PG, Kikinis R, Levitt JJ, Metcalf D, et al. Caudate, putamen, and globus pallidus volume on schizophrenia: a quantitative MRI study. Psychiatry Res 1995;61:209-29.
26. Raz N, Torres IJ, Acker JD. Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry. Neurobiol Learning Memory 1995;63:133-42.
27. Stevens JA. Abnormal reinnervation as a basis for schizophrenia: a hypothesis. Arch Gen Psychiatry 1992;49:238-43.
28. Roberts RC, Gaither LA Gao XM, Kashyap SM, Tamminga CA. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse 1995;20:3234-43.
29. Bilder RM, Wu H, Bogerts B, Degreef G, Ashtari M, Alvir JMJ, Synder PJ, Lieberman JA. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994;151:1437-47.
30. Breier A, Buchhanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 1992;49:921-6.
31. Feinberg I. Schizophrenia and late madurational brain changes in man. Psychophramacol Bull 1982; 18:29-31.
32. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991;48: 881-90.
33. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994;151: 1430-6.
34. Keshavan MS, Bagwell WW, Haas GL, Sweeney JA, Scholler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. Lancet 1994;344: 1434
35. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in firt-episode schizophrenic patients: preliminary findings. Biol Psychiatry 1995;38:349-60.
36. Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1996;153: 564-6.
37. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet 1995;345:456-7.